Antibacterial properties of ozone-containing preparations for treatment of cows and goats with gonado- and metropathology.
Abstract
The antibacterial properties of ozone-containing preparations for the treatment of cows and goats with gonado- and metropathology have been studied. It has been established that the drugs “OKO” and “Prozon” form the basis of ozone and propolistherapy, provide high efficiency and economic benefits for positive effects on the organism of animals and the absence of side effects. Treatment of cows and goats with acute postnatal catarrhal purulent endometritis was carried out according to a purposeful program, which is motivated by the principle of the action of the drugs. The program of antibiotic, nitrofuran and sulfanilamidotherapy replaced with the use of ozone-containing preparations “OKO” and “Prozon”. The results of the clinical evaluation indicate that the method of treating cows and goats using ozone-containing preparations has a high therapeutic efficacy. Thus, in experimental animals, the duration of the treatment period decreased by 1,1‒5,4 days compared with control, the period of the period from birth to live was reduced by 4,5‒15,3 days, and fertility increased by 9,1‒54,7 %. Comprehensive therapy of cows and goats with divergent pathology (hypoluteolysis↔subclinical endometritis) was carried out according to the program, which provides the final alternative: a) recovery with the restoration of the morpho-functional state of the endometrium; b) prophylactic therapy of cows with hypoluteolysis (delayed regression of the yellow body). The program “use of antibacterial drugs” has been replaced by ozone-containing preparations “OKO” and “Prozon”. It was established that compared with the control in experimental animals, the duration of treatment periods (for 1,6‒6,1 days) and the manifestation of acute after treatment (by 4,5‒12,6, fertility increased (by 21,4‒47,1 %). Due to the fact that the clinical recovery does not always indicate a complete cure, we conducted its control by conducting light optic and luminescent methods of cytological examination of cervical smears. The obtained data indicate positive changes in the characteristics of cervical smear and, accordingly, the effectiveness of ozone-containing preparations and their antibacterial properties. In particular, the number of epithelial cells and leukocytes decreased (by 19,6 or 64,7 %), as well as microbes (by 47,1 or 80,2 %) and cells with yellow-red coloration (by 6,2 % or 73,7 %) Positive is the dynamics of the ratio of the number of epithelial cells and leukocytes and epitheliocytes (from 1:3 to 1:1) with normal structure and dystrophy (from 1:3 to 2,5:1), as well as an increase in cells with a green color (3,8 or 102,9 %).References
Балушкина А.А. Основные принципы антибактериальной терапии в акушерской практике / А.А. Балушкина, В.Л. Тютюнник // Русский медицинский журнал. Акушерство и гинекология. – 2014. – № 19. – С. 1425–1427.
Возрастающая угроза развития антимикробной резистентности. Возможные меры. Всемирная организация здравоохранения, 2013. – 130 с [Электронный ресурс]. – Режим доступа: https://www.afro.who.int/sites/default/files/2017-06/9789244503188_rus.pdf.
Выбор основных лекарственных средств. Рациональное использование лекарственных средств // Информационный общественный ресурс медицинского специализированного научно-практического социально-рекламного журнала и ассоциации “Medical Express” [Электронный ресурс]. – Режим доступа : http://www.medicalexpress.uz/r/farm_news/id/607/.
Гулиева М.Г. Озонотерапия / М.Г. Гулиева, Э.И. Зейналова, Н.А. Фигарова // Офтальмология. – 2010. – № 2. – С. 102–109.
Гуртовой Б.Л. Применение антибиотиков в акушерстве и гинекологии / Б.Л. Гуртовой, В.И. Кулаков, С.Д. Воропаева. – М. : Триада-Х, 2004. – 176 c.
Донець Д.Г. Озонотерапія в клініці внутрішніх хвороб / Д.Г. Донець // Фармакологія та лікарська токсикологія. – 2009. – № 2(9). – С. 9–14.
Зупанець І.Л. Раціональне застосування лікарських засобів: ключові аспекти вирішення проблеми / І.Л. Зупанець, Т.В. Жукова [Електронний ресурс]. – Режим доступу: http://dspace.nuph.edu.ua/bitstream/123456789/4463/1/17-21%281%29.pdf.
Ільніцька Л.І. Механізми терапевтичного ефекту озонокисневих сполук за даними аналітичних досліджень / Л.І. Ільніцька // Галицький лікарський вісник. – 2007. – Т. 14, № 3. – С. 118–121.
Ільніцький М.Г. Озонотерапія як безпечний та перспективний метод у ветеринарній практиці / М.Г. Ільніцький, Р.В. Підборська // Вісник ЖНАЕУ. – 2015. – № 2(50), т. 1. – С. 348–354.
Качалина Т.С. Озоновые технологии в акушерстве и гинекологии / Т.С. Качалина, ГО. Гречканев. – Нижний Новгород: Изд-во Нижегородской госмедакадемии, 2007. – 292 с.
Клинические рекомендации. Акушерство и гинекология [4-е изд., перераб. и доп.]; под ред. В.Н. Серова, Г.Т. Сухих. – М.: ГЭОТАР-Медиа, 2014. – 1024 с.
Козлов Р.С. Стратегия использования антимикробных препаратов как попытка ренессанса антибиотиков / Р.С. Козлов, А.В. Голуб // Клиническая микробиология и антимикробная химиотерапия. – 2011. – № 13(4). – С. 322–334.
Конопельцев И.Г. Озонотерапия и озонопрофилактика воспалительных заболеваний и функциональных расстройств матки у коров : дис. … доктора вет. наук : 16.00.07 / И.Г. Конопельцев. – Киров, 2004. – 361 с.
Конопельцев И.Г. Применение озонированного подсолнечного масла при мастите у коров / И.Г. Конопельцев, Е.В. Видякина, В.А. Платонов // Ветеринария. – 2007. – № 2. – С. 35–37.
Кошевой В.П. Озономістські препарати та їх використання у ветеринарній репродуктології (методичні рекомендації) / [В.П. Кошевой, С.Я. Федоренко, С.В. Науменко та ін.]. – Харків, 2014. – 81 с.
Лекарственные средства в акушерстве и гинекологии. ‒ [3-е изд., испр. и доп.]; под ред. В.Н. Серова, Г.Т. Сухих. – М.: ГЭОТАР-Медиа, 2010. – 320 с.
Матвеев Л.В. КВЧ-терапия в клинической ветеринарной практике / Л.В. Матвеев, Е.И. Новикова // Вестник Нижегородского гос. ун-та им. Н.И. Лобачевского. – Н. Новгород, 2001. – Вып. 2(4). – С. 62–65.
Назаренко А.И. Озонотерапия телят при катаральной бронхопневмонии: дис. … канд. вет. наук: 16.00.01 / А.И. Назаренко. – Воронеж, 2000. – 148 с.
Никулин Д.М. Влияние озона на резистентность новорожденных телят / Д.М. Никулин, Г.Р. Реждепова // Ветеринария. – 2003. – № 3. – С. 40–42.
Озон и озонотерапия: монография / [И.С. Чекман, А.О. Сыровая, В.А. Макаров и др.]. – Київ–Харків, 2013. – 144 с.
Озонотерапія в акушерстві, гінекології та андрології / В.П. Кошевой, С.Я. Федоренко, С.В. Науменко [та ін.] // Ветеринарна медицина України. – 2014. – № 4(218). – С. 22–25.
Особенности применения антибактериальных препаратов в акушерской практике. Проблема антибиотикорезистентности [Электронный ресурс] / Л.В. Адамян, В.Н. Кузьмин, К.Н. Арсланян [и др.] // Лечащий врач: Медицинский научно-практический портал. – Режим доступа: https://www.lvrach.ru/2015/11/15436339/.
Рациональное использование лекарственных средств: ключевые моменты [Електронний ресурс] // Раціональна фармакотерапія. – 2007. – № 1(2). – Режим доступу: https://rpht.com.ua/ru-issue-article-14.
Сазонова В.В. Ветеринарная озонотерапия сегодня: “за” и “против” [Электронный ресурс] / В.В. Сазонова. – Режим доступа: http://www.econf.rae.ru/pdf/2013/02/2172.
Усманов Р.А. Озонотерапия при гнойно-воспалительных процессах у животных (клинико-лабораторные исследования): дис. ... канд. вет. наук: 16.00.05 / Р.А. Усманов. – Казань, 2002. – 210 с.
Bocci V.A. Biological and clinical effects of ozone. Has ozone therapy a future in medicine? / V.A. Bocci // Br. J. Biomed. Sci. – 1999. – Vol. 56, Is. 4. – P. 270–279.
Bocci V.A. Scientific and Medical Aspects of Ozone Therapy / V.A. Bocci // State of the Art. Archives of Medical Research. – 2006. – Vol. 37, Is. 4. – P. 425–435.
Elvis A.M. Ozone therapy: A clinical review / A.M. Elvis, J.S. Ekta // J. Nat. Sci. Biol. Med. – 2011. – Vol. 2. – P. 66–70.
European surveillance of antimicrobial consumption (ESAC): outpatient antibiotic use in Europe (1997–2009) / N. Adriaenssens, S. Coenen, A. Versporten [et al.] // J. Antimicrob. Chemother. – 2011. – Vol. 66(6). – P. 3–12.
Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility / Noel L. Smith, Anthony L. Wilson, Jason Gandhi [et al.] // Med. Gas. Res. – 2017. – Vol. 7(3). – P. 212–219.
Ozone therapy: clinical and basic evidence of its therapeutic potential / L. Re, M.N. Mawsouf, S. Menéndez [et al.] // Arch. Med. Res. – 2008. – Vol. 39(1). – P. 17–26.
Ozone: a multifaceted molecule with unexpected therapeutic activity / I. Zanardi, E. Borrelli, G. Valacchi [et al.] // Curr. Med. Chem. – 2016. – Vol. 23. – P. 304–314.
Protective effects of medical ozone combined with traditional Chinese medicine against chemically-induced hepatic injury in dogs / Li-Jie Li, Yun-Gao Yang, Zhi-Ling Zhang [et al.] // World Journal of Gastroenterology. – 2007. – № 45, Vol. 13. – Р. 5989–5994.
Tateda K. Antibiotic-resistant bacteria and new directions of antimicrobial chemotherapy / K. Tateda // RinshoByori. – 2012. – № 60(5). – P. 443–448.
The bacterial challenge: time to react [Electronic resource] / European Centre for Disease Prevention and Control, Stockholm, 2009. – Access mode: http://www.ecdc.europa.eu.
Viebahn-Hansle R. Ozontherapie-therapeutishe Grundidee und Wircsam-keitsmodelee / R. Viebahn-Hansle // Erfahrungsheilkunde. – 1991. – № 4. – P. 296‒315.
Viebahn-Hänsler Renate. Ozone in Medicine: The LowDose Ozone Concept-Guidelines and Treatment Strategies, Ozone: Science & Engineering / Renate Viebahn-Hänsler, Olga Sonia León Fernández & Ziad Fahmy // The Journal of the International Ozone Association. – 2012. – Vol. 34, Is. 6. – P. 408‒424.
WHO Global Strategy for Containment of Antimicrobial Resistance [Electronic resource]. – Access mode: http://www.who.int/drugresistance/WHO_Global_Strategy_ English.pdf.
Balushkina, A.A., Tyutyunnik, V.L. (2014). Basic principles of antibacterial therapy in obstetrical practice. Russian medical journal. Obstetrics and gynecology, 19, 1425–1427.
Increasing threat of development of antimicrobial resistance. Possible measures. World Health Organization (2013). 130. Available at: https://www.afro.who.int/sites/default/files/2017-06/9789244503188_rus.pdf.
Choice of essential medicines. Rational use of medicines. Information public resource of medical specialized scientific-practical social-advertising magazine and association “Medical Express”. Available at: http://www.medicalexpress.uz/r/farm_news/id/607/.
Guliyeva, M.G., Zeynalov, E.I., Figaro, N.A. (2010). Ozone therapy. Ophthalmology. 2, 102–109.
Gurtova, B.L., Kulakov, V.I., Voropaeva, S.D. (2004). The use of antibiotics in obstetrics and gynecology. Moscow: Triad-X, 176.
Donets, D.G. Ozone therapy in the clinic of internal diseases (2009) Pharmacology and drug toxicology. 2(9), 9–14.
Zupanets, I.L., Zhukova, T.V. Rational use of drugs: key aspects of problem solving. Available at: http://dspace.nuph.edu.ua/bitstream/123456789/4463/1/17-21%281%29.pdf.
Il’nitska, L.I. (2007). Mechanisms of the therapeutic effect of ozone-oxygen compounds on the basis of analytical studies. Galician Medicinal Herald. 14, 3, 118–121.
Il’nitsky, M.G., Pidbors’ka, R.V. (2015). Ozone therapy as a safe and promising method in veterinary practice. Bulletin of Zhytomyr National Agroecological University. 2(50), 1, 348–354.
Kachalina, T.S., Grechkanev, G.O. (2007). Ozone technologies in obstetrics and gynecology. Nizhny Novgorod: Publishing house of the Nizhny Novgorod state academy, 292.
Ed. by Serova, V.N., Sukhikh, G.T. (2014). Clinical recommendations. Obstetrics and gynecology. Moscow: GEOTAR-Media, 4, 1024.
Kozlov, R.S., Golub, A.V. (2011). The strategy of using antimicrobials as an attempt at a renaissance of antibiotics. Clinical microbiology and antimicrobial chemotherapy. 13(4), 322–334.
Konopel’tsev, I.G. (2004). Ozone therapy and ozonoprophylaxis of inflammatory diseases and functional disorders of the uterus in cows (The thesis abstract). Kirov, 361.
Konopel’tsev, I.G., Vidyakina, E.V., Platonov, V.A. (2007). Application of ozonized sunflower oil in mastitis in cows. Veterinary. 2, 35–37.
[Koshevoy, V.P., Fedorenko, S.Y., Naumenko, S.V. et al.]. (2014). Ozonistic drugs and their use in veterinary reproduction (methodical recommendations). Kharkiv, 81.
Ed. by Serova, V.N., Sukhikh, G.T. (2010). Medicines in obstetrics and gynecology. Moscow: GEOTAR-Media, 3, 320.
Matveev, L.V., Novikova, E.I. (2001). Extremely high frequency therapy in clinical veterinary practice. Bulletin of the Nizhny Novgorod State University. 2(4), 62–65.
Nazarenko, A.I. (2000). Ozonotherapy of calves with catarrhal bronchopneumonia (Thesis). Voronezh, 148.
Nikulin, D.M., Rezhdepova, G.R. (2003). Effect of ozone on the resistance of newborn calves. Veterinary, 3, 40–42.
[Chekmann, I.S., Syrovaya, A.O., Makarov, V.A. et al.]. (2013). Ozone and ozonotherapy: monograph. Kyiv–Kharkiv, 144.
Koshevoy, V.P., Fedorenko, S.Y., Naumenko, S.V. [et al.]. (2014). Ozonotherapy in obstetrics, gynecology and andrology. Veterinary Medicine of Ukraine. 4(218), 22–25.
Adamyan, L.V., Kuzmin, V.N., Arslanyan K.N. [et al.]. Features of antibacterial drugs in obstetric practice. The problem of antibiotic resistance. Treating physician: Medical Scientific and Practical Portal. Available at: https://www.lvrach.ru/2015/11/15436339/.
Rational use of medicines: key points. (2007). Rational pharmacotherapy. № 1(2). Available at: https://rpht.com.ua/ru-issue-article-14.
Sazonova V.V. Veterinary ozone therapy today: “for” and “against”. Available at: http://www.econf.rae.ru/pdf/2013/02/2172.
Usmanov, R.A. (2002). Ozonotherapy with purulent-inflammatory processes in animals (clinical and laboratory studies):thesis. Kazan’, 210.
Bocci, V.A. (1999). Biological and clinical effects of ozone. Has ozone therapy a future in medicine? Br. J. Biomed. Sci. 56, 4, 270‒279.
Bocci, V.A. (2006). Scientific and Medical Aspects of Ozone Therapy. State of the Art. Archives of Medical Research. 37, 4, 425‒435.
Elvis, A.M. (2011). Ozone therapy: A clinical review. J. Nat. Sci. Biol. Med. 2. 66–70.
Adriaenssens, N., Coenen, S., Versporten, A. et al. (2011). European surveillance of antimicrobial consumption (ESAC): outpatient antibiotic use in Europe (1997–2009). J. Antimicrob. Chemother. 66(6), 3–12.
Noel, L. Smith, Anthony, L. Wilson, Jason, Gandhi [et al.]. (2017). Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med. Gas. Res. 7(3), 212–219.
Re, L., Mawsouf, M.N., Menéndez, S. [et al.]. (2008). Ozone therapy: clinical and basic evidence of its therapeutic potential. Arch. Med. Res. 39 (1), 17‒26.
Zanardi, I., Borrelli, E., Valacchi G. [et al.]. (2016). Ozone: a multifaceted molecule with unexpected therapeutic activity. Curr. Med. Chem. 23, 304–314.
Li-Jie, Li, Yun-Gao, Yang, Zhi-Ling, Zhang [et al.]. (2007). Protective effects of medical ozone combined with traditional Chinese medicine against chemically-induced hepatic injury in dogs. World Journal of Gastroenterology. 45, 13, 5989–5994.
Tateda, K. (2012). Antibiotic-resistant bacteria and new directions of antimicrobial chemotherapy. RinshoByori. 60(5), 443–448.
The bacterial challenge: time to react (2009). European Centre for Disease Prevention and Control, Stockholm. Available at: http://www.ecdc.europa.eu.
Viebahn-Hansle, R. (1991). Ozontherapie-therapeutishe Grundidee und Wircsam-keitsmodelee. Erfahrungsheilkunde. 4, 296‒315.
Renate Viebahn-Hänsler, Olga Sonia León Fernández & Ziad Fahmy (2012). Ozone in Medicine: The LowDose Ozone Concept-Guidelines and Treatment Strategies, Ozone: Science & Engineering. The Journal of the International Ozone Association. 34, 6, 408‒424.
WHO Global Strategy for Containment of Antimicrobial Resistance. Available at: http://www.who.int/drugresistance/WHOGlobalStrategyEnglish.pdf.
